HDIM
CELG

Hanson & Doremus Investment Management’s Celgene Corp CELG Stock Holding History

Hanson & Doremus Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-429
Closed -$43K – 466
2019
Q3 		$43K Sell
429
-65
-13% -$6.18K 0.01% 298
2019
Q2 		$46K Sell
494
-400
-45% -$38K 0.01% 288
2019
Q1 		$84K Buy
894
+65
+8% +$5.68K 0.03% 235
2018
Q4 		$53K Hold
829
– – 0.02% 262
2018
Q3 		$74K Hold
829
– – 0.02% 253
2018
Q2 		$66K Hold
829
– – 0.02% 267
2018
Q1 		$74K Buy
829
+229
+38% +$22K 0.02% 267
2017
Q4 		$63K Hold
600
– – 0.02% 273
2017
Q3 		$87K Buy
600
+400
+200% +$54.5K 0.03% 238
2017
Q2 		$26K Hold
200
– – 0.01% 343
2017
Q1 		$25K Hold
200
– – 0.01% 330
2016
Q4 		$23.1K Hold
200
– – 0.01% 323
2016
Q3 		$21K Hold
200
– – 0.01% 314
2016
Q2 		$20K Hold
200
– – 0.01% 310
2016
Q1 		$20K Hold
200
– – 0.01% 318
2015
Q4 		$24K Sell
200
-19
-9% -$2.2K 0.01% 319
2015
Q3 		$24K Buy
219
+19
+10% +$2.36K 0.01% 305
2015
Q2 		$23K Hold
200
– – 0.01% 322
2015
Q1 		$23K Hold
200
– – 0.01% 324
2014
Q4 		$22K Hold
200
– – 0.01% 331
2014
Q3 		$19K Hold
200
– – 0.01% 327
2014
Q2 		$17K Hold
200
– – 0.01% 327
2014
Q1 		$14K Hold
200
– – 0.01% 337
2013
Q4 		$17K Hold
200
– – 0.01% 321
2013
Q3 		$15K Hold
200
– – 0.01% 319
2013
Q2 		$12K Buy
+200
New +$12K 0.01% 310

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Hanson & Doremus Investment Management's CELG Position: Q4 2019 in Review

Hanson & Doremus Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 429 shares — an estimated $43K sold.

Hanson & Doremus Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $87K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hanson & Doremus Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 429 Celgene Corp shares in Q4 2019, an estimated $43K.
  • Hanson & Doremus Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Hanson & Doremus Investment Management's Celgene Corp position peaked at $87K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2019, filed 16 Jan 2020.